{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:30:37Z","timestamp":1793712637193,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05417-z","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:02:23Z","timestamp":1693472543000},"page":"2193-2200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52\u00a0weeks: a phase III double-blind, randomized placebo-controlled trial"],"prefix":"10.1007","volume":"43","author":[{"given":"Sreeja S.","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Reji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankti","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Mohanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sageer","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Vinayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuroopa","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveri K.","family":"Nalianda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Padmaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaxon","family":"Alex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-1361","authenticated-orcid":false,"given":"Padmanabha","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"3","key":"5417_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","volume":"38","author":"C Yu","year":"2019","unstructured":"Yu C, Jin S, Wang Y et al (2019) Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis. Clin Rheumatol 38(3):727\u2013738","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5417_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semarthrit.2018.12.006","volume":"49","author":"IC Scott","year":"2019","unstructured":"Scott IC, Ibrahim F, Panayi G et al (2019) The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life. Semin Arthritis Rheum 49(1):20\u201326","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5417_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0006-291X(02)00633-2","volume":"295","author":"KC Das","year":"2002","unstructured":"Das KC, Das CK (2002) Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem Biophys Res Commun 295(1):62\u201366","journal-title":"Biochem Biophys Res Commun"},{"issue":"7636","key":"5417_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/541144a","volume":"541","author":"M Baker","year":"2017","unstructured":"Baker M (2017) Deceptive curcumin offers cautionary tale for chemists. Nature 541(7636):144\u2013145","journal-title":"Nature"},{"key":"5417_CR5","first-page":"632","volume":"71","author":"SD Deodhar","year":"1980","unstructured":"Deodhar SD, Sethi R, Srimal RC (1980) Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 71:632\u2013634","journal-title":"Indian J Med Res"},{"issue":"11","key":"5417_CR6","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"B Chandran","year":"2012","unstructured":"Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res PTR 26(11):1719\u20131725","journal-title":"Phytother Res PTR"},{"issue":"10","key":"5417_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/jmf.2017.3930","volume":"20","author":"A Amalraj","year":"2017","unstructured":"Amalraj A, Varma K, Jacob J et al (2017) A Novel Highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and Parallel-Group Study. J Med Food 20(10):1022\u20131030","journal-title":"J Med Food"},{"key":"5417_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104280","volume":"146","author":"CM White","year":"2019","unstructured":"White CM, Pasupuleti V, Roman YM, Li Y, Hernandez AV (2019) Oral turmeric\/curcumin effects on inflammatory markers in chronic inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 146:104280","journal-title":"Pharmacol Res"},{"key":"5417_CR9","doi-asserted-by":"publisher","first-page":"01021","DOI":"10.3389\/fphar.2020.01021","volume":"11","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J, Rayess YE, Rizk AA et al (2020) Turmeric and Its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical. Biotechnol Med Appl Front Pharmacol 11:01021","journal-title":"Biotechnol Med Appl Front Pharmacol"},{"issue":"11","key":"5417_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152(11):726\u2013732","journal-title":"Ann Intern Med"},{"issue":"4","key":"5417_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10067-017-3923-z","volume":"37","author":"JR Curtis","year":"2018","unstructured":"Curtis JR, Trivedi M, Haraoui B et al (2018) Defining and characterizing sustained remission in patients with rheumatoid arthritis. Clin Rheumatol 37(4):885\u2013893","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5417_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"issue":"10","key":"5417_CR13","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1136\/ard.2008.105577","volume":"69","author":"R O\u2019Mahony","year":"2010","unstructured":"O\u2019Mahony R, Richards A, Deighton C, Scott D (2010) Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 69(10):1823\u20131826","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5417_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/annrheumdis-2014-206439","volume":"75","author":"J Haschka","year":"2016","unstructured":"Haschka J, Englbrecht M, Hueber AJ et al (2016) Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis 75(1):45\u201351","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5417_CR15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10067-016-3285-y","volume":"35","author":"TF Galvao","year":"2016","unstructured":"Galvao TF, Zimmermann IR, da Mota LMH, Silva MT, Pereira MG (2016) Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 35(7):1659\u20131668","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5417_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5417_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ 73(7):1108\u20131123","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"11","key":"5417_CR18","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/S2665-9913(21)00220-4","volume":"3","author":"K Tascilar","year":"2021","unstructured":"Tascilar K, Hagen M, Kleyer A et al (2021) Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Rheumatol 3(11):e767\u2013e777","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"5417_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13075-015-0730-2","volume":"17","author":"IM Markusse","year":"2015","unstructured":"Markusse IM, Dirven L, Gerards AH et al (2015) Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther 17(1):232","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"5417_CR20","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/1756-185X.13688","volume":"22","author":"M Javadi","year":"2019","unstructured":"Javadi M, Khadem Haghighian H, Goodarzy S, Abbasi M, Nassiri-Asl M (2019) Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: a randomized, double-blind, controlled trial. Int J Rheum Dis 22(10):1857\u20131862","journal-title":"Int J Rheum Dis"},{"issue":"4167","key":"5417_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/164456a0","volume":"164","author":"E Schraufstatter","year":"1949","unstructured":"Schraufstatter E, Bernt H (1949) Antibacterial action of curcumin and related compounds. Nature 164(4167):456","journal-title":"Nature"},{"issue":"7","key":"5417_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/nu10070908","volume":"10","author":"E Asteriou","year":"2018","unstructured":"Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP (2018) Curcumin for the management of periodontitis and early ACPA-positive rheumatoid arthritis: killing two birds with one stone. Nutrients 10(7):908","journal-title":"Nutrients"},{"issue":"3","key":"5417_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00296-021-04859-7","volume":"42","author":"J Kabeerdoss","year":"2022","unstructured":"Kabeerdoss J, Sandhya P, Kurien BT, Scofield RH, Danda D (2022) In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren\u2019s syndrome. Rheumatol Int 42(3):545\u2013551","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"5417_CR24","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.3346\/jkms.2009.24.S1.S195","volume":"24","author":"J-S Han","year":"2009","unstructured":"Han J-S, Choi B-S, Yang C-W, Kim Y-S (2009) Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells. J Korean Med Sci 24(Suppl 1):S195-203","journal-title":"J Korean Med Sci"},{"key":"5417_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891822","volume":"13","author":"L Zeng","year":"2022","unstructured":"Zeng L, Yang T, Yang K et al (2022) Efficacy and safety of curcumin and curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial. Front Immunol 13:891822","journal-title":"Front Immunol"},{"issue":"4","key":"5417_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"G Shoba","year":"1998","unstructured":"Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64(4):353\u2013356","journal-title":"Planta Med"},{"issue":"12","key":"5417_CR27","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1007\/s13197-019-03986-1","volume":"56","author":"VSR Kotra","year":"2019","unstructured":"Kotra VSR, Satyabanta L, Goswami TK (2019) A critical review of analytical methods for determination of curcuminoids in turmeric. J Food Sci Technol 56(12):5153\u20135166","journal-title":"J Food Sci Technol"},{"issue":"4","key":"5417_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00296-022-05244-8","volume":"43","author":"ZD Koroljevi\u0107","year":"2023","unstructured":"Koroljevi\u0107 ZD, Jordan K, Ivkovi\u0107 J, Bender DV, Peri\u0107 P (2023) Curcuma as an anti-inflammatory component in treating osteoarthritis. Rheumatol Int 43(4):589\u2013616","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05417-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T07:03:46Z","timestamp":1697699026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5417"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05417-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SA has received honorarium as speaker from Pfizer, DrReddy\u2019s, Cipla and Novartis (unrelated to the current work). The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patients or the public WERE involved in the design, or conduct, or reporting, or dissemination plans of our research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient involvement statement"}}]}}